Personal information

No personal information available

Activities

Collapse all

Employment (1)

Fred Hutchinson Cancer Research Center: Seattle, WA, US

2015-03-01 to present | Research Technician II (Vaccine and Infectious Disease Division)
Employment
Source: Self-asserted source
Anna MacCamy

Education and qualifications (1)

University of Washington: Seattle, WA, US

2010-09-23 to 2014-12-12 | B.S. Molecular, Cellular, Developmental Biology
Education
Source: Self-asserted source
Anna MacCamy

Works (4)

Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain

Science Advances
2022-05-06 | Journal article
DOI: 10.1126/sciadv.abm3948
Contributors: Matthew D. Gray; Junli Feng; Connor E. Weidle; Kristen W. Cohen; Lamar Ballweber-Fleming; Anna J. MacCamy; Crystal N. Huynh; Josephine J. Trichka; David Montefiori; Guido Ferrari et al.
Source: check_circle
Crossref

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection

Science
2021-06-25 | Journal article
DOI: 10.1126/science.abg9175
Contributors: Leonidas Stamatatos; Julie Czartoski; Yu-Hsin Wan; Leah J. Homad; Vanessa Rubin; Hayley Glantz; Moni Neradilek; Emilie Seydoux; Madeleine F. Jennewein; Anna J. MacCamy et al.
Source: check_circle
Crossref

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation.

Immunity
2020-06-08 | Journal article
DOI: 10.1016/j.immuni.2020.06.001
PMID: 32561270
PMC: PMC7276322
Source: Self-asserted source
Anna MacCamy

Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization.

Cell reports
2019-12-01 | Journal article
DOI: 10.1016/j.celrep.2019.10.071
PMID: 31801073
PMC: PMC6936959
Source: Self-asserted source
Anna MacCamy
How many people are using ORCID?